CLE
Clinical trials for CLE explained in plain language.
Never miss a new study
Get alerted when new CLE trials appear
Sign up with your email to follow new studies for CLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets painful lupus skin rash
Disease control Recruiting nowThis study is testing whether an experimental drug called VENT-03 can reduce the severity of skin rashes caused by lupus. About 24 adults with active lupus skin rashes will take either VENT-03 or a placebo for 4 weeks, then all will take VENT-03 for 8 more weeks. Researchers will…
Matched conditions: CLE
Phase: PHASE2 • Sponsor: Ventus Therapeutics U.S., Inc. • Aim: Disease control
Last updated Apr 01, 2026 19:56 UTC
-
First human tests begin for promising new autoimmune disease drug
Disease control Recruiting nowThis early-stage study is testing a new drug called SAR448501 in adults with moderate-to-severe lupus or rheumatoid arthritis who haven't gotten enough relief from their current treatments. The main goal is to find safe dose levels and see how the drug behaves in the body. About …
Matched conditions: CLE
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC